Increased interleukin-13 levels in patients with chronic heart failure

International Journal of Cardiology

Volumn 131, Issue 3, 2009, Pages 421-423

  Nishimura, Yuki ^a   Inoue, Teruo ^a   Nitto, Takeaki ^a   Morooka, Toshifumi ^a   Node, Koichi ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Heart failure; Inflammation; Interleukin 13

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 13;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; C-REACTIVE PROTEIN; CHRONIC DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HUMANS; INTERLEUKIN-13; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; SEVERITY OF ILLNESS INDEX;

EID: 58149201061     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.128     Document Type: Article

References (11)

1. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
2. Sun M., Chen M., Dawood F., et al. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation 115 (2007) 1398-1407
3. Janssen S.P., Gayan-Ramirez G., Van den Bergh A., et al. Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111 (2005) 996-1005
4. Wills-Karp M., Lyuimbaz J., Xu X., et al. IL-13: central mediator of allergic asthma. Science 282 (1998) 2258-2261
5. Kolios G., Rooney N., Murphy C.T., Robertson D.A., and Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 43 (1998) 56-63
6. Fallon P.G., Richardson E.J., McKenzie G.J., and McKenzie A.N. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J Immunol 164 (2000) 2585-2591
7. Kawakami M., Kawakami K., and Puri R.K. Intratumor administration of interleukin 13 receptor-targeted cytotoxin induces apoptotic cell death in human malignant glioma tumor xenografts. Mol Cancer Ther 1 (2002) 999-1007
8. Jeon, S.G., Lee, C.G., Oh, M.H., Chun, E.Y., Gho, Y.S., Cho, S.H., Kim, J.H., Min, K.U., Kim, Y.Y., Kim, Y.K., Elias, J.A. Recombinant basic fibroblast growth factor inhibits the airway hyperresponsiveness, mucus production, and lung inflammation induced by an allergen challenge. J Allergy Clin Immunol in press.
9. Lee C.G., Kang H.R., Homer R.J., Chupp G., and Elias J.A. Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling. Proc Am Thorac Soc 3 (2006) 418-423
10. Inoue T., Kato T., Uchida T., et al. Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting. J Am Coll Cardol 46 (2005) 239-245
11. Inoue T., Komoda H., Nonaka M., Kameda M., Uchida T., and Node K. Interleukin-8 as an independent predictor of long-term clinical outcome in patients with coronary artery disease. Int J Cardiol (2007) [Epub ahead of print]